(lp0
S"Trading Options During Earnings in Impax Laboratories Inc  CML News - 1 hour ago We're going to examine buying and selling out of the money strangles in Impax Laboratories Inc and find out once and for all what the winning trades have been during earnings releases.ATR Watch: Impax Laboratories Inc.  - The Oracle ExaminerStock Price Impax Laboratories, Inc.  Compared to Index - Highland Mirror"
p1
aS'North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells ... GuruFocus.com - 6 hours ago North Tide Capital, Llc initiated holdings in Impax Laboratories Inc. The purchase prices were between $12.75 and $24.23, with an estimated average price of $17.1.'
p2
aS'Exclusive: Impax Laboratories taps Morgan Stanley for strategic review - sources Reuters - Mar 7, 2017 Generic drugmaker Impax Laboratories Inc  has asked investment bank Morgan Stanley  to help it conduct a strategic review, as it tries to cope with a tougher drug pricing environment, people familiar with the matter said.Impax Laboratories Inc.  Moves Higher on Volume Spike for March 06 - Equities.comWeatherford International, Impax Laboratories, Cytokinetics Upgraded - Schaeffers Research '
p3
aS'Impax to Present at Upcoming Investor Conferences PR Newswire  - Feb 27, 2017 Impax Laboratories, Inc.  is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous ...Impax Laboratories, Inc.  Scheduled to Post Earnings on Wednesday - Sports PerspectivesImpax Laboratories, Inc.  Receives An Update From Brokers - The De Soto Edge'
p4
aS'Earnings Reaction History: Impax Laboratories, Inc., 50.0% Follow-Through ... Nasdaq - Mar 1, 2017 Impax Laboratories, Inc.  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p5
aS'Impax Laboratories, Inc.  Files An 8-K Results of Operations and ... Market Exclusive - Mar 1, 2017 Impax Laboratories, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products , as well as the development and marketing of branded products.Impax Laboratories Inc.  Has Dropped To A New Low After Q4 Report - NasdaqImpax Laboratories Inc.  Plunges 14.44% on March 03 - Equities.com'
p6
aS'Impax Laboratories  is Oversold: Can It Recover? March 02, 2017 Zacks.com - Mar 2, 2017 Impax Laboratories, Inc.  has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.'
p7
aS'Impax Laboratories Inc.  Settles Into New 52-Week Low on March 07 Session Equities.com - Mar 7, 2017 Shares of Impax Laboratories Inc.  sank into a new 52-week low yesterday, and could be a company to watch at the open.'
p8
aS'Impax Laboratories Inc  Short Interest Update BNB Daily  - Mar 10, 2017 Impax Laboratories logo Impax Laboratories Inc  was the target of a large increase in short interest during the month of February.Susquehanna Bancshares Inc Downgrades Impax Laboratories Inc  to Neutral - The Cerbat Gem'
p9
aS'Renaissance Technologies LLC Increases Position in Impax Laboratories Inc  The Cerbat Gem - Mar 16, 2017 Impax Laboratories logo Renaissance Technologies LLC raised its position in shares of Impax Laboratories Inc  by 515.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC.Crazy Volume Spikes for: Impax Laboratories Inc.  - HugoPressThe Impax Laboratories Inc  Downgraded by Susquehanna Bancshares Inc to ... - Petro Global News 24'
p10
a.